Penumbra
PEN
$468.62
Share price
-4.01%
Change (1 day)
31.10%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
EPS for Penumbra (PEN)
EPS in 2023 (TTM): $1.21
According to Penumbra's latest financial reports the company's current EPS (TTM) is $1.34. In 2022 the company made an earnings per share (EPS) of -$0.10 a decrease over its 2021 EPS that were of $0.27.
EPS history for Penumbra from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.21 | -1271.14% |
| 2022 | -$0.10 | -138.6% |
| 2021 | $0.27 | -134.09% |
| 2020 | -$0.79 | -131.43% |
| 2019 | $2.50 | 636.84% |
| 2018 | $0.34 | 46.15% |
| 2017 | $0.23 | -73.47% |
| 2016 | $0.88 | 432.67% |
| 2015 | $0.16 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$0.08934 | -106.67% | 🇺🇸 USA |
 | $3.11 | 132.00% | 🇺🇸 USA |